SNPs in BRAP associated with risk of myocardial infarction in Asian populations

Nature Genetics

Volumn 41, Issue 3, 2009, Pages 329-333

  Ozaki, Kouichi ^a   Sato, Hiroshi ^b   Inoue, Katsumi ^c   Tsunoda, Tatsuhiko ^a   Sakata, Yasuhiko ^b   Mizuno, Hiroya ^b   Lin, Tsung Hsien ^d,e   Miyamoto, Yoshinari ^a   Aoki, Asako ^a   Onouchi, Yoshihiro ^a   Sheu, Sheng Hsiung ^d,e   Ikegawa, Shiro ^a   Odashiro, Keita ^c   Nobuyoshi, Masakiyo ^c   Juo, Suh Hang H ^d,e   Hori, Masatsugu ^b   Nakamura, Yusuke ^a   Tanaka, Toshihiro ^a  

^a RIKEN   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KOKURA MEMORIAL HOSPITAL   (Japan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; BRCA1 PROTEIN; GALECTIN 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMALL INTERFERING RNA;

ARTICLE; ASIAN; ATHEROSCLEROSIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HEART INFARCTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; JAPANESE; MACROPHAGE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTH MUSCLE FIBER; TAIWAN;

ANIMALS; ASIA; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL INFARCTION; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; RISK FACTORS; RNA, SMALL INTERFERING; UBIQUITIN-PROTEIN LIGASES;

EID: 61349108698     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.326     Document Type: Article

References (22)

1. Ozaki, K. et al. Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction. Nat. Genet. 32, 650-654 (2002).
2. Ozaki, K. et al. Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro. Nature 429, 72-75 (2004).
3. PROCARDIS Consortium. A trio family study showing association of the lymphotoxin-alpha N26 (804A) allele with coronary artery disease. Eur. J. Hum. Genet. 12, 770-774 (2004).
4. Clarke, R. et al. Lymphotoxin-alpha gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS case-control study. PLoS. Genet. 2, e107 (2006).
5. Asselbergs, F.W. et al. Effects of lymphotoxin-alpha gene and galectin-2 gene polymorphisms on inflammatory biomarkers, cellular adhesion molecules and risk of coronary heart disease. Clin. Sci. 112, 291-298 (2007).
6. Mangino, M. et al. LGALS2 functional variant rs7291467 is not associated with susceptibility to myocardial infarction in Caucasians. Atherosclerosis 194, 112-115 (2007).
7. Rigaut, G. et al. A generic protein purification method for protein complex characterization and proteome exploration. Nat. Biotechnol. 17, 1030-1032 (1999).
8. Barrett, J.C., Fry, B., Maller, J. & Daly, M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265 (2005).
9. Tregouet, D.A. & Garelle, V. A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics 23, 1038-1039 (2007).
10. International HapMap Consortium. A haplotype map of the human genome. Nature 437, 1299-1320 (2005).
11. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678 (2007).
12. Cordell, H.J. & Clayton, D.G. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am. J. Hum. Genet. 70, 124-141 (2002).
13. Ozaki, K. et al. A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanese population. Nat. Genet. 38, 921-925 (2006).
14. Heinemeyer, T. et al. Databases on transcriptional regulation: TRANSFAC, TRRD, and COMPEL. Nucleic Acids Res. 26, 362-367 (1998).
15. Li, S. et al. Identification of a novel cytoplasmic protein that specifically binds to nuclear localization signal motifs. J. Biol. Chem. 273, 6183-6189 (1998).
16. Matheny, S.A. et al. Ras regulates assembly of mitogenic signalling complexes through the effector protein IMP. Nature 427, 256-260 (2004).
17. Ory, S. & Morrison, D.K. Signal transduction: implications for Ras-dependent ERK signaling. Curr. Biol. 14, R277-R278 (2004).
18. O'Neill, L.A. Targeting signal transduction as a strategy to treat inflammatory diseases. Nat. Rev. Drug Discov. 5, 549-563 (2006).
19. Karin, M. & Delhase, M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin. Immunol. 12, 85-98 (2000).
20. Breslow, J.L. Cardiovascular disease burden increases, NIH funding decreases. Nat. Med. 3, 600-601 (1997).
21. Mizuno, H. et al. Impact of atherosclerosis-related gene polymorphisms on mortality and recurrent events after myocardial infarction. Atherosclerosis 185, 400-405 (2006).
22. Andrews, N.C. & Faller, D.V. A rapid micropreparation teqhnique fore extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19, 2499 (1991).